Is Big Pharma Focusing More on US-Based Manufacturing?

Amgen's billion-dollar US investments in manufacturing and packaging are the latest infusion of Big Pharma "Made-in-America” dollars. Experts weigh on the trend's costs, benefits, and industry prognosis.